From Strategic Ambition to Measurable Impact: Takeaways from Three Life Sciences Conferences

Over the past several weeks, the Atlas team attended three industry events: the 30th American Pharma and Biotech Project, Program and Portfolio Management Conference in Boston, the 2026 BioNJ C-Suite Summit, and the EP3M Summit in Boston.

While each conference approached life sciences challenges from a different perspective, a common theme emerged: organizations have ambitious goals and increasingly powerful technologies, but struggle to make the decisions and changes needed to turn those ambitions into measurable results.

AI is changing what organizations can analyze, predict, and automate. At the same time, leaders are managing crowded portfolios, competition for specialized resources, organizational complexity, and growing pressure to demonstrate business value.

What stood out across these discussions was not a lack of technology or ambition, but the challenge of connecting strategic priorities, informed decision-making, and the organizational changes needed to translate new capabilities into measurable results.

Here are six takeaways we believe deserve closer attention.

1. AI Can Expose Resource Conflicts. It Cannot Make Them Disappear.

One of the more engaging discussions took place at PPM Summit Boston, where Atlas' Rishi Dixit and Pfizer's Sarah Blendermann challenged the audience with "AI Will Solve Everything, Except This."

The debate centered on a familiar problem in pharma R&D: if AI is making planning and forecasting more sophisticated, why do organizations still struggle with resource conflicts?

Part of the answer is that identifying a conflict and resolving it are two different things.

AI can show where demand exceeds capacity, identify competing commitments, and help leaders explore different scenarios. It can also demonstrate what happens when a program is accelerated, a critical resource is reassigned, or an investment is delayed. However, it cannot eliminate competing business priorities, resolve organizational friction, or secure agreement among stakeholders with different objectives.

Those challenges require leadership judgment, organizational alignment, and a willingness to make difficult choices.

When there is not enough capacity to do everything, something must change. An initiative may need to be delayed, its scope reduced, or resources moved from another priority.

Leaders must also establish who has the authority to make those decisions and ensure that affected teams understand the implications.

Every yes is a no. Committing resources to one initiative means those resources are unavailable somewhere else.

The real opportunity with AI is to make the consequences of these choices more visible so leaders can address them earlier, with better information and greater clarity about what is being gained or given up.

2. Effective Portfolio Management Connects the Entire Organizational Ecosystem

One takeaway from the EP3M Summit stayed with our Atlas team: portfolio management works best when it creates connections across the organizational ecosystem.

Strategy, investment, resources, risk, and execution are closely related, yet organizations often manage them through separate functions, processes, and systems. Improving one part of that structure does not necessarily resolve the disconnects between them.

A new portfolio management platform, for example, may improve visibility into project status without addressing how investment decisions are made or how resources are allocated. Similarly, a stronger planning process will have limited impact if changes in business priorities are not reflected in the work teams are expected to deliver.

The EP3M discussions reinforced the importance of making strategy specific enough to guide real choices. An organization can have a collection of compelling initiatives, but if those initiatives compete for the same funding, expertise, or leadership attention, portfolio management must help determine which combination the business can realistically support.

This also changes the purpose of portfolio reviews. Rather than focusing primarily on status updates, reviews should provide opportunities to challenge assumptions, reconsider priorities, and make decisions about where resources should go. When new competitive intelligence, emerging risks, or material changes in business conditions affect an investment, leaders should be prepared to respond rather than wait for the next scheduled review.

Competitive intelligence has an important role in this process because it can help organizations test their assumptions before committing significant resources. AI can further support these discussions by reducing the time required to gather and organize information, giving teams more opportunity to evaluate alternatives and understand their implications.

However, more sophisticated analysis does not remove the need for human validation, judgment, or accountability.

The broader lesson from EP3M was that portfolio effectiveness depends on how well an organization connects decisions across functions, not simply how well it manages individual projects.

Understanding the organizational ecosystem means recognizing how one decision affects other programs, functions, regions, and business objectives. It also requires bringing the right perspectives into the conversation before choices are made.

For Atlas, these discussions reinforced the importance of connecting portfolio discipline with program execution and the people responsible for carrying decisions through the organization.

3. Program Management Needs to Be More Than Managing the Plan

Another theme, particularly relevant to the portfolio and program management discussions in Boston, was the changing expectations of program and project management professionals.

Strong delivery fundamentals remain essential. Organizations need people who can manage dependencies, coordinate teams, anticipate problems, and maintain momentum across complex programs. However, managing execution is only one part of the role.

Program leaders also need to understand why the work matters, how it supports strategic objectives, and what other parts of the business may be affected by the decisions being made. This requires looking beyond the immediate project team and understanding the broader organizational environment.

A decision that benefits one program may create a resource problem for another, while a missed dependency may have consequences well beyond the team responsible for it. Changes in business priorities can also mean that an existing delivery plan, even one that is being executed successfully, is no longer the right plan.

Program leaders are often well positioned to recognize these connections because they work across functions and see how decisions play out in practice. Their value increases when they use that perspective to inform and influence decisions rather than simply report progress.

A project can be delivered on time and within budget while still falling short of the business outcome that justified its investment. Recognizing that possibility requires program leaders to challenge assumptions, communicate trade-offs, and keep the intended business results in view.

Realizing that value also depends on how senior leaders engage with program managers. Treating them as contributors to decisions, and welcoming those who bring forward candid insights, emerging risks, and difficult trade-offs, helps ensure that delivery experience informs business choices. This perspective is especially valuable when it challenges an assumption or signals that a decision needs to be revisited.

Program management should therefore also be understood as program leadership. It combines the discipline needed to execute with the judgment, business understanding, and influence needed to help organizations make better decisions throughout delivery.

4. More Data Does Not Automatically Mean Better Decisions

Life sciences organizations have no shortage of dashboards, reports, and performance metrics, but the volume of information available does not necessarily improve the quality of decisions.

Reporting often grows over time as new measures are introduced, dashboards become more detailed, and teams devote increasing effort to preparing updates. Despite that investment, leadership discussions can still end with basic questions about what has changed, why it matters, and what needs to happen next.

The challenge is not simply collecting more information. It is identifying which information is meaningful enough to influence a decision.

This theme surfaced in discussions about portfolio governance, program execution, and AI-enabled analytics across the conferences.

AI and advanced analytics can help organizations bring information together from different systems, identify patterns, and explore the implications of changing conditions. These capabilities can reduce the effort involved in gathering data and create more time for interpretation and analysis. However, technology does not eliminate the need to decide which information deserves attention.

One practical approach is to work backward from the decision that needs to be made. Leaders should consider what they need to know, which factors could change their course of action, and which measures provide useful insight rather than simply additional detail.

The same principle applies to risk management.

A long risk register may demonstrate that issues are being documented, but it does not necessarily show whether the most consequential risks are understood or being addressed. Effective risk discussions should focus on what could materially affect outcomes, who is responsible for responding, and when leadership involvement is required.

The value of reporting ultimately lies in whether it helps organizations recognize changes, understand their consequences, and act while there is still an opportunity to influence the decision.

5. AI Impact Requires More Than Technology

At the BioNJ C-Suite Summit, the conversation around AI focused less on what technology might do and more on what it will take to make it useful in practice.

Atlas COO Vicki McColley moderated the panel, “Continued Innovation & Advancements in Generative & Agentic AI in BioPharma,” which examined where AI is beginning to move beyond experimentation and what organizations need to do next.

The discussion reinforced a clear point: a successful pilot does not automatically create business value. AI can help accelerate clinical development, improve operational efficiency, strengthen planning, support decision-making, and reduce the time required to gather and analyze information. However, those benefits depend on how well the technology is applied and integrated into the organization, and that begins with choosing the right problems to solve.

Organizations need to identify use cases tied to a specific business need, define what success looks like, and decide how AI will fit into existing workflows. They also need reliable data, clear ownership, appropriate security controls, and a process for reviewing and acting on AI-generated outputs.

These considerations are especially important in life sciences, where AI may interact with regulated processes, sensitive data, and valuable intellectual property. Organizations need to be clear about what data a tool can access, how its outputs will be validated, and who remains accountable for the decisions made using that information.

Workforce readiness also matters. Teams need practical guidance on when AI is useful, when it should be questioned, and how it changes their role. Leaders need to set priorities, make time for adoption, and address concerns before introducing new tools at scale.

The central message from the BioNJ C-Suite Summit was straightforward: the companies that gain the most from AI will not necessarily be the ones that move first. They will be the ones that choose the right problems, put the right controls in place, and make the changes needed to use AI reliably in everyday work.

6. Governance, Risk, and Culture Shape an Organization's Ability to Execute

The EP3M Summit reinforced that strong portfolio and program management depends on more than processes and governance structures and requires an organizational culture in which people have the information, authority, and trust needed to make decisions and act on them. This becomes particularly important in global organizations, where enterprise objectives must be balanced with regional priorities and operating realities.

Successful integration requires more than imposing common standards across locations. Regional teams need meaningful opportunities to contribute to decisions, clear expectations about how they work with other functions, and visible opportunities to develop within the organization. Without that involvement, even well-designed operating models can struggle to gain traction.

Further, culture and trust are equally important when managing risk. Teams may identify and document risks without bringing them to the attention of leaders who can influence the decisions. Concerns can remain within a function because ownership is unclear, escalation feels uncomfortable, or acknowledging a potential problem is perceived as a sign of poor performance. By the time a risk materializes, the opportunity to respond effectively may already be limited.

Senior leaders need visibility into the risks that could materially affect business decisions, along with enough context to understand the potential consequences and available responses. Their involvement also helps establish a culture in which risks can be raised, discussed, and accepted with a clear understanding of the implications.

The same thinking applies to decisions about stopping, delaying, or redirecting programs. When changing course is consistently treated as failure, teams have little incentive to challenge existing commitments, even when the evidence suggests that a different approach would be better.

Lastly, governance should make it easier for organizations to respond to new information, not create additional barriers to action. Clear decision rights, credible analysis, and trust across functions give leaders the foundation to make difficult choices and help teams follow through.

Turning Conversations into Better Decisions

For life sciences leaders, the opportunity is to turn these insights into action. This means strengthening portfolio governance, making resource trade-offs more transparent, empowering program leaders to influence business decisions, and embedding AI where it can deliver measurable value. Equally important is building a culture that encourages collaboration, challenges assumptions, and adapts as priorities change.

At Atlas, these conversations reinforce what we have long believed and put into practice: true impact comes from bringing people, processes, technology, and business priorities together to enable better decisions and more effective execution.

Ultimately, success will not be defined by how much technology an organization adopts, but by how effectively it turns intelligence into decisions, decisions into action, and action into measurable business outcomes.